English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/113510
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


Expression of MicroRNA-15b and the glycosyltransferase GCNT3 correlates with antitumor efficacy of rosemary diterpenes in colon and pancreatic cancer

AuthorsGonzález-Vallinas, Margarita; Molina, Susana; Vicente, G. ; Zarza, Virginia; Martín-Hernández, Roberto; Rodríguez García-Risco, Mónica ; Fornari, Tiziana ; Reglero, Guillermo ; Ramírez de Molina, Ana
Issue Date2014
PublisherPublic Library of Science
CitationPLoS ONE 9(6): e98556 (2014)
AbstractColorectal and pancreatic cancers remain important contributors to cancer mortality burden and, therefore, new therapeutic approaches are urgently needed. Rosemary (Rosmarinus officinalis L.) extracts and its components have been reported as natural potent antiproliferative agents against cancer cells. However, to potentially apply rosemary as a complementary approach for cancer therapy, additional information regarding the most effective composition, its antitumor effect in vivo and its main molecular mediators is still needed. In this work, five carnosic acid-rich supercritical rosemary extracts with different chemical compositions have been assayed for their antitumor activity both in vivo (in nude mice) and in vitro against colon and pancreatic cancer cells. We found that the antitumor effect of carnosic acid together with carnosol was higher than the sum of their effects separately, which supports the use of the rosemary extract as a whole. In addition, gene and microRNA expression analyses have been performed to ascertain its antitumor mechanism, revealing that up-regulation of the metabolic-related gene GCNT3 and down-regulation of its potential epigenetic modulator miR-15b correlate with the antitumor effect of rosemary. Moreover, plasmatic miR-15b down-regulation was detected after in vivo treatment with rosemary. Our results support the use of carnosic acid-rich rosemary extract as a complementary approach in colon and pancreatic cancer and indicate that GCNT3 expression may be involved in its antitumor mechanism and that miR-15b might be used as a non-invasive biomarker to monitor rosemary anticancer effect. © 2014 González-Vallinas et al.
Publisher version (URL)http://dx.doi.org/10.1371/journal.pone.0098556
Identifiersdoi: 10.1371/journal.pone.0098556
issn: 1932-6203
Appears in Collections:(CIAL) Artículos
Files in This Item:
File Description SizeFormat 
MicroRNA-15b.pdf751,88 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.